Allesh Biosciences Labs adopts molecular modeling and computer-aided drug design (CADD) technologies for the design of novel pharmacophores and small molecular entities/scaffolds that could lead to drug candidates and novel therapeutic agents/medicines.

We deliver value by integrating deep domain skills with exceptional operational competency and strategic consulting capability across the drug discovery value chain:

Potential areas for in silico intervention in drug discovery process

AlleshBio takes advantage of industry leading computational drug discovery technologies based on quantum mechanics/quantum chemistry, molecular mechanics and statistical mechanics in molecular modeling and drug design.

Our customized solutions help pharmaceutical companies, research centers, and R&D laboratories to successfully accelerate the hit identification and lead optimization process to develop new drug candidates that have the potential to become novel therapeutics/medicines.

We optimize hit-molecules to potential leads by means of chemoinformatics, computational chemistry and chemogenomics approaches.

Combining expertise in computational chemistry, chemoinformatics, bioinformatics and chemogenomics, we offer a complete package of in silico services and solutions to support drug discovery.